American Century Companies’s Catalyst Pharmaceutical CPRX Stock Holding History

American Century Companies's CPRX Position: Q2 2026 in Review

American Century Companies increased its Catalyst Pharmaceutical (CPRX) stake by 34% in Q2 2026, buying an estimated $41.8M and bringing the position to 5,553,921 shares worth $175M. The position accounts for 0.08% of the portfolio, ranked #259.

American Century Companies first reported a position in CPRX in Q2 2020 and has held it in 25 quarters since. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

• American Century Companies held 5,553,921 shares of Catalyst Pharmaceutical worth $175M as of Q2 2026.
• American Century Companies bought 1,415,505 Catalyst Pharmaceutical shares in Q2 2026, an estimated $41.8M.
• Catalyst Pharmaceutical made up 0.08% of American Century Companies's portfolio in Q2 2026, its #259 holding.
• American Century Companies first reported a position in Catalyst Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
• 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.